{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:22:01Z","timestamp":1758759721531,"version":"3.44.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93137","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:49:25Z","timestamp":1758743365000},"source":"Crossref","is-referenced-by-count":0,"title":["Facial Abnormalities Following Warfarin Exposure In Utero"],"prefix":"10.7759","author":[{"given":"Sharon","family":"Nyesiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Happy L","family":"Mbabazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samalie M","family":"Kitooleko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Nabbaale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062178","article-title":"The global burden of valvular heart disease: from clinical epidemiology to management","volume":"12","author":"Santangelo G","year":"2023","unstructured":"Santangelo G, Bursi F, Faggiano A, et al.. The global burden of valvular heart disease: from clinical epidemiology to management. J Clin Med. 2023, 12:10.3390\/jcm12062178","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0813-5","article-title":"Prevalence and characteristics of primary left-sided valve disease in a cohort of 15,000 patients undergoing echocardiography studies in a tertiary hospital in Uganda","volume":"18","author":"Rwebembera J","year":"2018","unstructured":"Rwebembera J, Manyilirah W, Zhu ZW, et al.. Prevalence and characteristics of primary left-sided valve disease in a cohort of 15,000 patients undergoing echocardiography studies in a tertiary hospital in Uganda. BMC Cardiovasc Disord. 2018, 18:82. 10.1186\/s12872-018-0813-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian A","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022, 43:561-632. 10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.011973","article-title":"Reoperation of left heart valve bioprostheses according to age at implantation","volume":"124","author":"Chan V","year":"2011","unstructured":"Chan V, Malas T, Lapierre H, et al.. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011, 124:S75-80. 10.1161\/CIRCULATIONAHA.110.011973","journal-title":"Circulation"},{"key":"ref5","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan WS","year":"2000","unstructured":"Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000, 160:191-6.","journal-title":"Arch Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy,","volume":"68","author":"Hall JG","year":"1980","unstructured":"Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy,. Am J Med. 1980, 68:122-40. 10.1016\/0002-9343(80)90181-3","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling Y","year":"1984","unstructured":"Stirling Y, Woolf L, North WR, Segatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984, 52:176-82. 10.1055\/s-0038-1661167","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.4.881.881","article-title":"Functional and immunologic protein S levels are decreased during pregnancy","volume":"68","author":"Comp PC","year":"1986","unstructured":"Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986, 68:881-5. 10.1182\/blood.V68.4.881.881","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)","volume":"132","author":"van Hagen IM","year":"2015","unstructured":"van Hagen IM, Roos-Hesselink JW, Ruys TP, et al.. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015, 132:132-42. 10.1161\/CIRCULATIONAHA.115.015242","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-59","article-title":"Impaired carboxylation of osteocalcin in warfarin-treated patients","volume":"64","author":"Menon RK","year":"1987","unstructured":"Menon RK, Gill DS, Thomas M, Kernoff PB, Dandona P. Impaired carboxylation of osteocalcin in warfarin-treated patients. J Clin Endocrinol Metab. 1987, 64:59-61. 10.1210\/jcem-64-1-59","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)34689-8","article-title":"The \u2018warfarin window\u2019 in pregnancy: the importance of half-life","volume":"32","author":"Walfisch A","year":"2010","unstructured":"Walfisch A, Koren G. The \u2018warfarin window\u2019 in pregnancy: the importance of half-life. J Obstet Gynaecol Canada, vol. 32, no. 10, pp. 988-989. 2010, 32:988-9. 10.1016\/S1701-2163(16)34689-8","journal-title":"J Obstet Gynaecol Canada, vol. 32, no. 10, pp. 988-989"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2014.03.001","article-title":"Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves","volume":"28","author":"McLintock C","year":"2014","unstructured":"McLintock C. Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. Best Pract Res Clin Obstet Gynaecol. 2014, 28:519-36. 10.1016\/j.bpobgyn.2014.03.001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-0982-9","article-title":"Warfarin embryopathy: fetal manifestations","volume":"457","author":"Wainwright H","year":"2010","unstructured":"Wainwright H, Beighton P. Warfarin embryopathy: fetal manifestations. Virchows Arch. 2010, 457:735-9. 10.1007\/s00428-010-0982-9","journal-title":"Virchows Arch"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007344","article-title":"Fetal warfarin syndrome","volume":"2012","author":"Starling LD","year":"2012","unstructured":"Starling LD, Sinha A, Boyd D, Furck A. Fetal warfarin syndrome. BMJ Case Rep. 2012, 2012:10.1136\/bcr-2012-007344","journal-title":"BMJ Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2018.02.005","article-title":"Warfarin embryopathy: balancing maternal and fetal risks with anticoagulation therapy","volume":"59","author":"Ferreira S","year":"2018","unstructured":"Ferreira S, Costa R, Malveiro D, Vieira F, Tuna M. Warfarin embryopathy: balancing maternal and fetal risks with anticoagulation therapy. Pediatr Neonatol. 2018, 59:534-5. 10.1016\/j.pedneo.2018.02.005","journal-title":"Pediatr Neonatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021, 143:e72-e227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404971-facial-abnormalities-following-warfarin-exposure-in-utero","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:49:26Z","timestamp":1758743366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404971-facial-abnormalities-following-warfarin-exposure-in-utero"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.93137","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}